Literature DB >> 11831443

Increased expression of CD25 and HLA-DR on lymphocytes recruited into the peritoneal cavity in non-infected CAPD patients.

A Brauner1, B Hylander, S H Jacobson, A Moshfegh, J Lundahl.   

Abstract

The impact of uremia per se, peritoneal dialysis (PD) and hemodialysis (HD) treatment was evaluated on characteristics of lymphocytes. CD4, CD8, CD25 and HLA-DR were analyzed, with flow cytometry, in lymphocytes prepared from peripheral blood of uremic (n = 10) and hemodialysis patients (n = 10). Peritoneal dialysate was also obtained from patients on CAPD (n = 12). A decreased relative and absolute lymphocyte count was observed in peripheral blood from uremic, HD and CAPD patients compared to healthy controls (p < 0.03, p < 0.03 and p < 0.02, respectively). On the other hand, the relative distribution of lymphocytes was significantly higher in peritoneal dialysate compared to peripheral blood of CAPD patients (p < 0.02). Likewise, the absolute CD4 positive lymphocyte count was lower in the peripheral blood from uremic. HD and CAPD patients as compared to healthy controls (p < 0.001, respectively). In CAPD patients the relative distribution of CD4 positive cells (p < 0.001) was lower, while quantitative CD25 level (p < 0.01) and the relative count of HLA-DR (p < 0.0001) was increased in the peritoneal dialysate compared to blood. Taken together a selective activation of lymphocytes in peritoneal dialysate as compared to peripheral blood from uremic, HD and CAPD patients was observed. The altered biological function of the inflammatory cells may therefore explain the increased susceptibility to infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11831443     DOI: 10.1023/a:1012806815330

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

1.  Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.

Authors:  L Chatenoud; B Dugas; G Beaurain; M Touam; T Drueke; A Vasquez; P Galanaud; J F Bach; J F Delfraissy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD).

Authors:  M Kozioł-Montewka; A Ksiazek; L Janicka; I Baranowicz
Journal:  Inflamm Res       Date:  1997-04       Impact factor: 4.575

3.  Myoinositol may be a factor in uremic immune deficiency.

Authors:  P Bartnicki; Z Zbróg; Z Baj; H Tchórzewski; M Luciak
Journal:  Clin Nephrol       Date:  1997-03       Impact factor: 0.975

4.  Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.

Authors:  A Brauner; Y Lu; G Halldén; B Hylander; J Lundahl
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

5.  Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.

Authors:  D Degiannis; M Czarnecki; D Donati; L Homer; R P Eisinger; K Raska; J Raskova
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

6.  Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure.

Authors:  H Dumann; S Meuer; K H Meyer zum Büschenfelde; H Köhler
Journal:  Kidney Int       Date:  1990-12       Impact factor: 10.612

7.  Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients.

Authors:  J J Sennesael; P Van der Niepen; D L Verbeelen
Journal:  Kidney Int       Date:  1991-07       Impact factor: 10.612

Review 8.  The beta 1-integrin (CD29) receptors: mediators of T lymphocyte--extracellular matrix recognition that affect adhesion, activation and lymphokine secretion.

Authors:  R Hershkoviz; S Miron; L Cahalon; O Lider
Journal:  Isr J Med Sci       Date:  1993-05

9.  In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients.

Authors:  G Beaurain; C Naret; L Marcon; G Grateau; T Drueke; P Urena; D L Nelson; J F Bach; L Chatenoud
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

10.  Peritonitis in children on continuous ambulatory peritoneal dialysis.

Authors:  H Mocan; A V Murphy; T J Beattie; T A McAllister
Journal:  J Infect       Date:  1988-05       Impact factor: 6.072

View more
  2 in total

1.  Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis.

Authors:  Gareth W Roberts; Duncan Baird; Kathleen Gallagher; Rhiannon E Jones; Christopher J Pepper; John D Williams; Nicholas Topley
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

2.  Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid.

Authors:  Rebecca Herzog; Lilian Kuster; Julia Becker; Tobias Gluexam; Dietmar Pils; Andreas Spittler; Manoj K Bhasin; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.